2 min read

Our Newest Study Shows AstraGin® Supports Probiotics and Intestinal Barrier Health

Probiotics are only as effective as the environment they’re delivered into. New preclinical research suggests that AstraGin® helps create a more supportive intestinal environment by strengthening barrier integrity and supporting probiotic adhesion, even under inflammatory conditions.

The study, AstraGin® improves intestinal barrier function and probiotic adhesion in human intestinal Caco-2 cells, was recently published in Bioactive Compounds in Health and Disease. It provides new insight into how AstraGin® supports gut health at the cellular level.

How the Study Was Designed

Researchers used a widely accepted human intestinal cell model to evaluate AstraGin®’s effects on barrier function and probiotic activity. To simulate inflammatory stress, cells were exposed to lipopolysaccharide (LPS), a compound commonly used in gut health research.

The study evaluated markers related to:

  • Intestinal barrier integrity
  • Cellular energy status
  • Probiotic growth and adhesion, specifically Lactobacillus rhamnosus

Key Findings: Supporting Probiotic Performance

Under inflammatory conditions, AstraGin® showed measurable benefits across multiple markers of gut barrier health. Treatment supported barrier integrity, helped restore tight junction protein expression, and improved cellular energy status compared to inflamed cells.

The study also found that AstraGin® enhanced the growth and adhesion of Lactobacillus rhamnosus to intestinal epithelial cells—even in the presence of inflammation. This is especially relevant for probiotic and synbiotic formulations, where adhesion and persistence in the gut are critical to performance.

How This Study Builds on Existing Human Research

While these findings are based on a controlled cell model, they align with earlier human research on AstraGin®. Previous studies in human subjects have shown support for a more favorable gut microbiota profile, including beneficial and probiotic-associated bacteria and improved microbial balance compared to placebo.

Together, the human data and this new preclinical research suggest that AstraGin® helps support both the intestinal environment and the beneficial microbes that rely on it.

What This Means for Gut Health Formulations

By supporting intestinal barrier structure and creating conditions that favor probiotic adhesion, AstraGin® adds value to gut health, probiotic, and synbiotic formulations, extending its role beyond nutrient absorption into broader healthy gut support.

Read the Full Study

The full published study is available below for those who would like to review the complete data set and methodology.